Similar Papers

Paper Title
Journal
Date
Author
From personalized to patient-specific treatment of metastatic melanoma.
Robert O Dillman
Melanoma Management | VOL. 2
Robert O DillmanRobert O Dillman
01 Aug 2015
Neoantigens in the immuno-oncology space.
Philip M Arlen
Future Oncology | VOL. 13
Philip M ArlenPhilip M Arlen
01 Oct 2017
Abstract 4845: Microarray analysis of melanoma autologous tumor cell lines used as the source of tumor associated antigens in patient-specific dendritic cell immunotherapy phase II trial in patients with metastatic melanoma
Andrew N Cornforth ... Gary Fogel
Cancer Research | VOL. 75
Andrew N Cornforth, et. al.Andrew N Cornforth ... Gary Fogel
01 Aug 2015
Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses
Robert O Dillman ... Andrew N Cornforth
Journal for ImmunoTherapy of Cancer | VOL. 6
Robert O Dillman, et. al.Robert O Dillman ... Andrew N Cornforth
06 Mar 2018
View more papers

More From: Melanoma Management

Paper Title
Journal
Date
Author
A rare and challenging case of amelanotic subungual melanoma from Syria
Muhammad Anas Kudsi ... Aladdin Etr
Melanoma Management | VOL. 11
Muhammad Anas Kudsi, et. al.Muhammad Anas Kudsi ... Aladdin Etr
29 Dec 2025
Patterns in progression from early-stage melanoma to late-stage melanoma: implications for survivorship follow-up
David J Savage ... Pauline Funchain
Melanoma Management | VOL. 11
David J Savage, et. al.David J Savage ... Pauline Funchain
02 Dec 2024
BRAF-mutant melanoma management: a single center retrospective analysis of patients treated with sequential therapy
Ilaria Proietti ... Concetta Potenza
Melanoma Management | VOL. -
Ilaria Proietti, et. al.Ilaria Proietti ... Concetta Potenza
29 Nov 2024
Immune checkpoint inhibitors in pediatric patients with melanoma: a systematic literature review
Charmy Vyas ... Nishu Gaind
Melanoma Management | VOL. 11
Charmy Vyas, et. al.Charmy Vyas ... Nishu Gaind
26 Aug 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.